Singbao International Co Ltd
Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coat… Read more
Market Cap & Net Worth: Singbao International Co Ltd (6130)
Singbao International Co Ltd (TWO:6130) has a market capitalization of $42.11 Million (NT$1.39 Billion) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #24794 globally and #1516 in its home market, demonstrating a -17.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Singbao International Co Ltd's stock price NT$31.45 by its total outstanding shares 44300000 (44.30 Million).
Singbao International Co Ltd Market Cap History: 2015 to 2026
Singbao International Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $34.04 Million to $42.11 Million (2.28% CAGR).
Singbao International Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Singbao International Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
Singbao International Co Ltd's market cap is 0.16 times its annual revenue
0.84x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $34.04 Million | $244.93 Million | -$3.48 Million | 0.14x | N/A |
| 2016 | $34.67 Million | $178.58 Million | $2.23 Million | 0.19x | 15.53x |
| 2017 | $67.46 Million | $85.77 Million | -$10.31 Million | 0.79x | N/A |
| 2018 | $43.24 Million | $53.72 Million | -$23.45 Million | 0.81x | N/A |
| 2019 | $38.36 Million | $63.47 Million | -$16.43 Million | 0.60x | N/A |
| 2020 | $28.16 Million | $137.87 Million | -$26.88 Million | 0.20x | N/A |
| 2021 | $50.43 Million | $103.81 Million | $32.47 Million | 0.49x | 1.55x |
| 2022 | $39.47 Million | $85.17 Million | $1.28 Million | 0.46x | 30.93x |
| 2023 | $45.41 Million | $231.12 Million | -$80.04 Million | 0.20x | N/A |
| 2024 | $31.53 Million | $195.35 Million | -$33.43 Million | 0.16x | N/A |
Competitor Companies of 6130 by Market Capitalization
Companies near Singbao International Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Singbao International Co Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Singbao International Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Singbao International Co Ltd's market cap moved from $34.04 Million to $ 42.11 Million, with a yearly change of 2.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$42.11 Million | -29.33% |
| 2025 | NT$59.58 Million | +88.96% |
| 2024 | NT$31.53 Million | -30.57% |
| 2023 | NT$45.41 Million | +15.05% |
| 2022 | NT$39.47 Million | -21.73% |
| 2021 | NT$50.43 Million | +79.07% |
| 2020 | NT$28.16 Million | -26.59% |
| 2019 | NT$38.36 Million | -11.29% |
| 2018 | NT$43.24 Million | -35.90% |
| 2017 | NT$67.46 Million | +94.59% |
| 2016 | NT$34.67 Million | +1.84% |
| 2015 | NT$34.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Singbao International Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.11 Million USD |
| MoneyControl | $42.11 Million USD |
| MarketWatch | $42.11 Million USD |
| marketcap.company | $42.11 Million USD |
| Reuters | $42.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.